Holen Sie sich die Stockscreener-App
9.50
0.52%
-0.05
Handel nachbörslich:
9.50
Enfusion Inc Aktie (ENFN) Neueste Nachrichten
There May Be Some Bright Spots In Enfusion's (NYSE:ENFN) Earnings - Yahoo Finance
Where are the Opportunities in (ENFN) - Stock Traders Daily
Enfusion (NYSE:ENFN) Sees Large Volume IncreaseHere's Why - MarketBeat
Enfusion Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Impax Asset Management Group plc Increases Holdings in Enfusion, Inc. (NYSE:ENFN) - MarketBeat
New York State Common Retirement Fund Sells 107,008 Shares of Enfusion, Inc. (NYSE:ENFN) - MarketBeat
Enfusion, Inc. (NYSE:ENFN) Q3 2024 Earnings Call Transcript - MSN
Enfusion, Inc. Reports Strong Q3 2024 Results - TipRanks
Earnings call: Enfusion reports robust Q3 growth with strong client gains - Investing.com Canada
Enfusion, Inc. (ENFN) Q3 Earnings and Revenues Miss Estimates - MSN
Discover 3 US Growth Companies With High Insider Ownership - Simply Wall St
Here's What Key Metrics Tell Us About Enfusion (ENFN) Q3 Earnings - Yahoo Finance
Enfusion Q3 Revenue Rises; Revises Outlook - Nasdaq
Enfusion earnings missed, revenue fell short of estimates By Investing.com - Investing.com UK
Enfusion Announces Third Quarter 2024 Results - StockTitan
When the Price of (ENFN) Talks, People Listen - Stock Traders Daily
Enfusion: 3 Strength, 3 Caveats, 3 Ways For Extra Income And Margin Of Safety (ENFN) - Seeking Alpha
Why Private Equity Will Buyout Enfusion (NYSE:ENFN) - Seeking Alpha
Enfusion, Inc. (NYSE:ENFN) Short Interest Update - MarketBeat
FTV Capital Named to Inc.’s Founder-Friendly Investors List for Fourth Consecutive Year - StockTitan
Enfusion (ENFN) to Release Quarterly Earnings on Monday - MarketBeat
Enfusion's general counsel Matthew Campobasso sells $6,032 in stock - Investing.com
Enfusion's general counsel Matthew Campobasso sells $6,032 in stock By Investing.com - Investing.com Canada
Enfusion, Inc.'s (NYSE:ENFN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - Yahoo Finance
(ENFN) On The My Stocks Page - Stock Traders Daily
Enfusion, Inc. (ENFN): This Fintech Stock Is Riding the AI Wave Higher - Insider Monkey
Exclusive-Financial software maker Enfusion explores options including sale, sources say - AOL
20 Fintech Stocks Riding the AI Wave Higher - Insider Monkey
SG Americas Securities LLC Makes New Investment in Enfusion, Inc. (NYSE:ENFN) - MarketBeat
Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation - Financial IT
Enfusion Expands Leadership Team - citybiz
Enfusion, Inc. (NYSE:ENFN) Shares Purchased by Dimensional Fund Advisors LP - MarketBeat
Squarepoint Ops LLC Takes $683,000 Position in Enfusion, Inc. (NYSE:ENFN) - MarketBeat
Insiders At Enfusion Sold US$13m In Stock, Alluding To Potential Weakness - Simply Wall St
Renaissance Technologies LLC Grows Holdings in Enfusion, Inc. (NYSE:ENFN) - MarketBeat
Enfusion Announces Date of Third Quarter 2024 Results - StockTitan
Enfusion Inc (ENFN) may enjoy gains as insiders got busy in the recent days - Knox Daily
Ratios Reveal: Breaking Down Enfusion Inc (ENFN)’s Financial Health - The Dwinnex
Clearline Capital LP Sells 70,738 Shares of Enfusion, Inc. (NYSE:ENFN) - MarketBeat
Enfusion (ENFN) Moves 5.0% Higher: Will This Strength Last? - MSN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enfusion, Inc.ENFN - PR Newswire
Logos Global Management LP Lowers Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Enlivex Progresses to Phase II for Knee Arthritis Treatment - TipRanks
Enfusion, Inc. (NYSE:ENFN) Shares Purchased by Scalar Gauge Management LLC - MarketBeat
Check Out Enfusion Inc (ENFN)’s Trade Data Rather Than the Analysts’ Views - SETE News
ENFN’s Market Balancing Act: Weighing Gains and Losses in 2023 - The InvestChronicle
Enfusion (NYSE:ENFN) Stock Price Up 4.3% - MarketBeat
ENFNEnfusion, Inc. Latest Stock News & Market Updates - StockTitan
1.04%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):